Chronic Obstructive Pulmonary Disease Exacerbations covers the definition, diagnosis, epidemiology, mechanisms, and treatment associated with COPD exacerbations. This text also addresses imaging and how it plays a pivotal role in the diagnosis and study of exacerbations.Written by today's top experts, Chronic Obstructive Pulmonary Disease Exacerbat

This text aids practitioners who seek to diagnose, treat and manage patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) more effectively. It discusses pulmonary gas exchange, muscle function and breathing, water/electrolyte imbalances and end-stage disease.

This volume provides an overview of exacerbation models of asthma and chronic obstructive pulmonary disease (COPD). Within this wide field the book focuses on experimental systems that mimic pathobiological processes likely to be critical in exacerbations of these conditions. To generate insight into the mechanisms of exacerbation of pulmonary disease and to promote the discovery of future treatments, both animal models and human experimental models are described. For this update some of the most eminent scientists within the area of pulmonology could be recruited to share their knowledge of this evolving field of human medicine. Models of Exacerbations in Asthma and COPD will be of great interest to pulmonologists, allergologists, specialists in internal medicine and critical care, as well as to microbiologists, infectiologists and pharmacologists studying the response to respiratory infections.

The field of acute exacerbations in chronic respiratory disease is challenging: definitions of acute exacerbations differ amongst the diseases and their severity has proven difficult to define. The Guest Editors of this Monograph tackle this challenging area by bringing together articles from internationally recognised experts in the field of acute exacerbations in chronic lung diseases. The book is separated into three sections: the first considers the definition, severity and consequences of exacerbations in each disease; the second looks at exacerbation triggers; and the third discusses the treatment and prevention of exacerbations using pharmacological and non-pharmacological interventions. The book’s structure allows comparisons between the definitions, short- and long-term consequences, triggers and therapeutic management of different respiratory diseases. It serves as a complete reference that raises awareness about the importance of acute exacerbations in patients with chronic lung diseases.

Appropriate for the clinician managing COPD in either the primary or secondary care setting, Clinicians' Guide to COPD considers epidemiology, diagnosis and management, concentrating on how patients really present to the clinician. Aspects of disease prevention, including lifestyle change, particularly smoking cessation, are discussed in detail. Ac

This clinical reference for practitioners offers a new and comprehensive look at chronic obstructive lung disease. Global in scale and importance, it is an important cause of morbidity and mortality. Bringing together a roster of internationally renowned contributors from the front lines of pulmonary medicine and research, it is aimed at practitioners in pulmonary medicine, pathology, thoracic radiology and epidemiology. Its focus is on the pathobiology of chronic obstructive pathology disease and emphysema and its exacerbation of chronic obstructive pulmonary disease and on treatment options. This reference works to 'connect the dots' by collating and centralizing the various data on the subject.

Clinics Collections: Chronic Obstructive Pulmonary Disease is the most current, comprehensive, and complete resource on the clinical management of COPD and related conditions. Clinics Collections: Chronic Obstructive Pulmonary Disease draws from Elsevier’s robust Clinics Review Articles database to provide multidisciplinary teams, including general practitioners, pulmonologists, sleep specialists, radiologists,and critical care nurses, with practical clinical advice and insights on this highly prevalent condition and its comorbidities. Clinics Collections: Chronic Obstructive Pulmonary Disease guides readers on how to apply current primary research findings on COPD to everyday practice to help overcome challenges and complications, keep up with new and improved treatment methods, and improve patient outcomes. Areas of focus include pathogenesis, COPD and secondary disorders, clinical considerations and complications, treatment and pharmacotherapy, and special considerations. Each article begins with keywords and key points for immediate access to the most critical information. Articles are presented in an easy-to-digest and concisely worded format. Elsevier’s Clinics Collections provide concise reviews of today’s most prevalent conditions and significant medical developments. Other Clinics Collections titles available include Type II Diabetes Mellitus, Asthma, Obesity, Pain Management, and Lipid Disorders.

Chronic obstructive pulmonary disease (COPD) is an increasingly important health problem world-wide. Whereas most other leading diseases have shown a decline in the past decades, COPD morbidity and mortality is on a steady increase. Exacerbations are usually defined as an increase in cough, a change in the colour or quantity of sputum, and a worsening dyspnea. The role of bacterial infections and the efficacy of antimicrobial therapy in acute exacerbations of chronic bronchitis (AECD) is still controversial. Exacerbations of chronic bronchitis are a common occurrence in clinical practice and are a leading cause of antibiotic prescription among respiratory infections. It is still uncertain whether each new exacerbation may deteriorate the natural history of chronic bronchitis. Undoubtedly, every episode includes a temporary worsening in lung function and may therefore pose the threat of respiratory failure or death in more severely obstructed patients.

Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases of the developed world and interest in the condition is burgeoning both among physicians encountering the disorder and within the pharmaceutical industry. International guidelines for diagnosis and management have been formulated and our basic understanding